ANALYTICS

The information contained on this web page is only a summary of information presented in more detail in the Settlement Notice. Because this website is just a summary, you should review the Notice for additional details... This case, In re Heartware International, Inc. Securities Litigation, Civil Action No. 1:16-cv-00520-RA, brought in the United States District Court for the Southern District of New York, arises out of allegations HeartWare and its then-CEO, Douglas E. Godshall made a series of alleged misstatements and omissions about the safety and commercial viability of HeartWare's new product, a heart pump called the "MVAD." Specifically, Lead Plaintiff alleges that Defendants misrepresented HeartWare's progress in remedying deficiencies in its processes for manufacturing and testing the MVAD that had been identified in a warning letter from the U.S. Food and Drug Administration ("FDA") and made misstatements and omissions about the safety and commercial prospects of the MVAD...

Also known as: Heartware International, Inc., HeartWare Securities Litigation

Primary location: Chanhassen United States